Ocugen (OCGN) Change in Account Payables (2014 - 2019)
Ocugen's (OCGN) quarterly Change in Account Payables came in at -$560000.0 in Q2 2019, down 166.27% YoY from $845000.0 in Q2 2018, and down 14.05% on a QoQ basis from -$491000.0 in Q1 2019.
Powered by 
Analysis
Ocugen (OCGN) Change in Account Payables (2014 - 2019) Analysis & Trends
Ocugen (OCGN) has 6 years of Change in Account Payables data on file, last reported at -$560000.0 in Q2 2019.
- Quarterly Change in Account Payables fell 166.27% year-over-year to -$560000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was -$2.9 million (down 617.57% YoY) and the FY2018 annual result came in at -$375000.0, up 55.83% from the prior year.
- Change in Account Payables slipped to -$560000.0 in Q2 2019, from -$491000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.2 million in Q3 2015 to a low of -$1.8 million in Q1 2015.
- A 5-year average of -$33611.1 and a median of -$225500.0 in 2016 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 1033.82% in 2015, down 5450.0% in 2015.
- Tracing OCGN's Change in Account Payables over 5 years: stood at -$772000.0 in 2015, then soared by 129.15% to $225000.0 in 2016, then sank by 139.11% to -$88000.0 in 2017, then tumbled by 1304.55% to -$1.2 million in 2018, then jumped by 54.69% to -$560000.0 in 2019.
- The last three Change in Account Payables figures came in at -$560000.0 (Q2 2019), -$491000.0 (Q1 2019), and -$1.2 million (Q4 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | -560,000.00 |
| Mar 31, 2019 | -491,000.00 |
| Dec 31, 2018 | -172,000.00 |
| Sep 30, 2018 | -570,000.00 |
| Jun 30, 2018 | 845,000.00 |
| Mar 31, 2018 | 586,000.00 |
| Dec 31, 2017 | -88,000.00 |
| Sep 30, 2017 | -401,000.00 |
| Mar 31, 2017 | -360,000.00 |
| Dec 31, 2016 | 238,000.00 |
| Sep 30, 2016 | 514,000.00 |
| Jun 30, 2016 | 385,000.00 |
| Mar 31, 2016 | 357,000.00 |
| Dec 31, 2015 | 295,000.00 |
| Sep 30, 2015 | -476,000.00 |
| Jun 30, 2015 | -844,000.00 |
| Mar 31, 2015 | -1.82 Mn |
| Dec 31, 2014 | 33,000.00 |
| Sep 30, 2014 | 2.17 Mn |
| Jun 30, 2014 | -207,000.00 |